Skip to main content

Prescription medicine

Xenon xe 133

Xenon xe 133 is a prescription medicine with an FDA approval on record since 1974. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the xenon xe 133 FDA label on DailyMed (effective September 10, 2026, Shine Spect USA, LLC); the NDA 17284 record on Drugs@FDA; every xenon xe 133 label on DailyMed.

Highlights of the record

FDA label of September 10, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

Inhalation of Xenon Xe 133 Gas has proved valuable for the evaluation of pulmonary function and for imaging the lungs.

Forms and strengths

Gas.

On the market

Earliest approval on file
October 10, 1974 Xenon Xe 133, Shine; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
3 of which 0 under generic applications, 3 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
13 through July 30, 2026

What is xenon xe 133 used for?

From the label: indications and usage

Inhalation of Xenon Xe 133 Gas has proved valuable for the evaluation of pulmonary function and for imaging the lungs. It may also be applied to assessment of cerebral flow.

FDA pharmacologic class: Inhalation Diagnostic Agent.

Source: FDA drug label (Xenon), Shine Spect USA, LLC, effective September 10, 2026 (SPL set 74f95143-d3b4-4e69-b200-e09bf811516b), via openFDA; the full label on DailyMed

Is there a generic for xenon xe 133?

No generic xenon xe 133 is approved (Drugs@FDA, October 8, 2026).

  • 1974 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do FAERS reports show for xenon xe 133?

The FDA Adverse Event Reporting System holds 13 reports that list xenon xe 133 among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 2 are coded as a death and 1 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Occupational Exposure To Product4
  • Nasal Discomfort2
  • Throat Irritation2
  • Urticaria2
  • Accidental Exposure1
  • Accidental Exposure To Product1
  • Alanine Aminotransferase Decreased1
  • Beta 2 Microglobulin Increased1

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Xenon xe 133 side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other